MedinGlobal

Edit Template

Rosinox 60 mg

In Stock

Rosinox 60 mg is listed as an Enoxaparin sodium injection, a low-molecular-weight heparin used to help prevent or treat certain blood clots. It works by enhancing natural anticoagulant activity, particularly against clotting factor Xa. It is prescribed for selected patients with deep vein thrombosis, pulmonary embolism or other clot-related conditions, depending on the indication and prescribed regimen. Bleeding, kidney impairment and low platelet counts are important safety considerations. The exact brand, concentration and syringe presentation require confirmation.

Medinglobal provides product information and medicine enquiry coordination. Availability and any subsequent supply are subject to confirmation by an authorised independent provider and applicable regulations.

Rosinox 60 mg – Composition, Uses and Medicine Enquiries

Product Overview

Rosinox 60 mg is listed as an Enoxaparin sodium injection, a low-molecular-weight heparin that helps prevent or treat certain blood clots.

Enoxaparin works by enhancing natural anticoagulant activity, particularly against clotting factor Xa. Doctors use it in selected patients with deep vein thrombosis, pulmonary embolism or other clot-related conditions, depending on the indication and prescribed regimen.

Treatment decisions depend on the diagnosis, patient-specific factors, coexisting conditions, possible medicine interactions and the applicable approved product information.

The exact brand, marketer, concentration and syringe presentation require confirmation against the actual product packaging before this product page is published.

Composition and Strength

The supplied product information identifies the following composition:

Active Ingredient Strength
Enoxaparin sodium 60 mg

Product Name: Rosinox 60 mg

Generic Name: Enoxaparin sodium

Brand Name: Rosinox

Strength: 60 mg

Presentation: To be verified against the actual manufacturer-labelled product.

Please verify the precise formulation, concentration, injection presentation and manufacturer details against the original product packaging before publishing this product page or proceeding with an enquiry.

Therapeutic Category and Indication

Rosinox 60 mg belongs to the anticoagulant category and is classified as a low-molecular-weight heparin.

Its clinical use relates to the prevention or treatment of venous thromboembolism, as prescribed.

Enoxaparin works by enhancing natural anticoagulant activity, particularly against clotting factor Xa. Doctors use it in selected patients with deep vein thrombosis, pulmonary embolism or other clot-related conditions, depending on the indication and prescribed regimen.

Treatment decisions depend on diagnosis, patient-specific factors, coexisting conditions, interactions and the applicable approved product information.

The listed indications are a general overview, not a substitute for a prescriber’s assessment. The exact approved uses and restrictions should be checked against the product’s current local prescribing information.

Administration Information

Rosinox 60 mg should be administered only by the prescribed injection route and schedule after professional instruction.

Patients should not self-adjust the prescribed schedule based on symptoms or combine this medicine with other blood thinners without medical review.

The prescribed schedule, duration, missed-dose instructions and monitoring requirements must be provided by the treating clinician.

Patients should not start, switch or stop prescription therapy on the basis of website information.

Product Presentation and Availability

The product enquiry can be made using the following details:

  • Product Name: Rosinox 60 mg
  • Generic Name: Enoxaparin sodium
  • Brand Name: Rosinox
  • Strength: 60 mg
  • Therapeutic Category: Anticoagulant
  • Medicine Class: Low-Molecular-Weight Heparin
  • Indication: Prevention or treatment of venous thromboembolism, as prescribed.
  • Presentation: To be verified.

The dosage form, concentration, syringe presentation and pack size must be matched to the actual manufacturer-labelled presentation.

Available packaging, batch identification, expiry date and remaining shelf life may vary and should be confirmed by an authorised supplier before any transaction.

No pack quantity, stock position or export eligibility is guaranteed by this listing.

Prescription and Patient Safety

Rosinox 60 mg is an anticoagulant medicine that must be used under appropriate medical guidance.

Bleeding, kidney impairment and low platelet counts are important safety considerations.

Patients should not independently adjust their prescribed treatment or combine this medicine with other blood thinners without medical review.

The appropriate treatment regimen and monitoring requirements depend on the patient’s condition and the treating clinician’s assessment.

The exact precautions, monitoring requirements and possible adverse effects should be checked against the current approved product information.

Medicine Enquiry Coordination Through Medinglobal

Medinglobal receives medicine-related enquiries and may help patients, caregivers and eligible healthcare organisations communicate with independent, appropriately authorised pharmaceutical suppliers or service providers.

Medinglobal does not itself manufacture, dispense, sell or export this medicine.

Availability, prescription requirements, lawful supply routes, supporting documents and any destination-country restrictions must be confirmed by the relevant authorised provider.

Submission of an enquiry is not a commitment or guarantee of supply.

How to Submit a Rosinox 60 mg Enquiry

To help identify the requested product, include the following details when submitting an enquiry:

  1. Product or brand name: Rosinox 60 mg.
  2. Generic name: Enoxaparin sodium.
  3. Required strength and dosage form.
  4. Required quantity.
  5. Destination country.
  6. Whether the request is for an individual patient or a healthcare institution.
  7. Valid prescription or other supporting documentation, where required.

Medinglobal may refer the enquiry to an appropriately authorised independent partner for verification and response.

Any subsequent transaction is subject to the partner’s own legal, clinical and regulatory checks.

Frequently Asked Questions

What is Rosinox 60 mg used for?

Rosinox 60 mg is associated with the prevention or treatment of venous thromboembolism, as prescribed. Eligibility and approved indications depend on the specific product label and clinician assessment.

What does Rosinox 60 mg contain?

The supplied product information identifies Enoxaparin sodium 60 mg. The precise formulation and presentation should be verified against the original product packaging.

Can I use this medicine without medical advice?

No. Prescription medicines and specialist therapies require qualified clinical oversight.

Can international patients enquire through Medinglobal?

Enquiries may be submitted, but lawful coordination and any supply depend on authorised partners and applicable local rules.

Does Medinglobal sell or dispense Rosinox 60 mg directly?

No. Medinglobal receives medicine-related enquiries and may help communicate with independent, appropriately authorised pharmaceutical suppliers or service providers. It does not itself manufacture, dispense, sell or export this medicine.

Product Name

Generic Name

Brand Name

Composition

Strength

Therapeutic Category

Medicine Class

Indication

Dosage Form

Route of Administration

Reviews

There are no reviews yet.

Be the first to review “Rosinox 60 mg”

Your email address will not be published. Required fields are marked *

Related Products

Pharmaceutical Disclaimer

Medinglobal Platform does not sell, dispense, manufacture or prescribe medicines. Pharmaceutical information on this page is provided solely for general information, product identification and enquiry coordination. Product listing is not medical advice, a recommendation or an offer for sale by Teji Radiance or the Medinglobal Partnership Firm. Prescription medicines require a valid prescription where applicable. Any regulated pharmaceutical activity is undertaken by the relevant independent provider subject to applicable law. Always consult an appropriately qualified healthcare professional before using or changing any medicine.

Scroll to Top